Gokhale Pranav 4
4 · Churchill Capital Corp X/Cayman · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Infleqtion (INFQ) CTO Pranav Gokhale Receives Award
What Happened
- Pranav Gokhale, Chief Technology Officer, was granted/received a mix of common shares and derivative awards on Feb 13, 2026 in connection with the merger that changed Churchill Capital Corp X’s name to Infleqtion, Inc. The filing shows a total of 2,898,347 shares/units across multiple entries. Two entries list 2,338,980 and 293,828 shares acquired at $0.00 (merger consideration); the remaining amounts (260,552; 347; 3,859; 781) are reported as derivative securities (converted/issued options or option-like awards) with N/A price/value.
Key Details
- Transaction date: Feb 13, 2026; Form 4 filed Feb 18, 2026 (filed five calendar days after the transactions; Form 4s are typically due within two business days, so this appears to be late).
- Total securities reported: 2,898,347 shares/units (2,632,808 shares reported as specific share amounts including two $0.00 entries; 265,539 reported as derivative securities).
- Reported cash paid: $0 for the entries that list $0.00 (merger consideration); derivative entries show N/A for price/value.
- Shares owned after transaction: not specified in the provided excerpt.
- Notable footnotes:
- F1: Securities were received pursuant to the Agreement and Plan of Merger and Reorganization (ColdQuanta merger) and the issuer changed its name to Infleqtion, Inc.
- F3: Legacy ColdQuanta stock options were converted into rights to receive Issuer stock options with same terms.
- F2/F4/F5: Vesting details vary by grant — some grants were already partially or fully vested (F2: 50% vested May 10, 2024 with monthly vesting thereafter; F4: fully vested; F5: 1/48th monthly vesting commencing Feb 17, 2026).
Context
- These are awards and converted legacy option grants tied to a merger, not open-market purchases or sales. Derivative entries reflect option/award instruments (rights to receive shares under specified vesting schedules) rather than immediate cash transactions. Such merger-related issuances are routine corporate restructuring mechanics and do not by themselves indicate a buy/sell trading decision by the insider.
Insider Transaction Report
Form 4
Gokhale Pranav
Chief Technology Officer
Transactions
- Award
Common Stock
[F1]2026-02-13+2,338,980→ 2,338,980 total - Award
Stock Option (Right to Buy)
[F1][F3][F2]2026-02-13+260,552→ 260,552 totalExercise: $0.67Exp: 2032-08-25→ Common Stock (260,552 underlying) - Award
Stock Option (Right to Buy)
[F1][F3][F4]2026-02-13+347→ 347 totalExercise: $0.67Exp: 2033-05-30→ Common Stock (347 underlying) - Award
Stock Option (Right to Buy)
[F1][F3][F4]2026-02-13+3,859→ 3,859 totalExercise: $0.90Exp: 2034-03-10→ Common Stock (3,859 underlying) - Award
Stock Option (Right to Buy)
[F1][F3][F4]2026-02-13+781→ 781 totalExercise: $0.90Exp: 2034-06-05→ Common Stock (781 underlying) - Award
Stock Option (Right to Buy)
[F5]2026-02-13+293,828→ 293,828 totalExercise: $13.22Exp: 2036-02-12→ Common Stock (293,828 underlying)
Footnotes (5)
- [F1]Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer").
- [F2]50% of the stock option vested and became exercisable on May 10, 2024, and thereafter the remainder vest in 24 equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
- [F3]Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions.
- [F4]Fully vested.
- [F5]1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date.
Signature
/s/ Jason D. Hall, Attorney-in-Fact|2026-02-18